The importance of quality control in the IVD industry cannot be overstated. Accurate and reliable testing is critical for patient care, and the use of quality control products is essential to ensure that test results are both accurate and consistent.

Currently, In Vitro Diagnostics Quality Control Market is growing at a Compound Annual Growth Rate (CAGR) of 5.3 % to reach USD 1.4 billion by 2026. The increasing demand for quality control in clinical laboratories and the increasing awareness about the importance of quality control in the IVD industry are the major drivers for this market growth. The emergence of advanced technologies such as biochemistry and immunochemistry, and the growing demand for quality control solutions from emerging economies are other factors contributing to the growth of this market.

Request for assumptions & how numbers were triangulated.

Key Market Trends

Infectious Disease Testing Segment is Expected to Register Fastest Growth

Infectious diseases testing is the most common type of in vitro diagnostic testing, and is expected to account for the fastest growth rate. This is primarily due to the increasing prevalence of infectious diseases, such as HIV, Hepatitis, and Tuberculosis. Moreover, the increasing efforts by government bodies to increase the awareness about these diseases and the increasing demand for point-of-care testing are further propelling the market growth.

North America is the largest Market

The North American region is expected to hold the largest share of the market during the forecast period. This is mainly due to the presence of a well-established healthcare system in the region, coupled with the presence of advanced technology and the availability of skilled professionals.

Moreover, factors such as the increasing prevalence of chronic diseases, rising demand for point-of-care testing, and the presence of major players in the region are further driving the market growth.

Competitive Landscape

The in vitro diagnostics (IVD) quality control market is highly competitive, with several major players dominating the industry. The market is characterized by intense competition, technological advancements, and increasing demand for quality control products.

Some of the major players in the IVD quality control market include:

Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
Randox Laboratories Ltd.
Siemens Healthineers AG
Abbott Laboratories
Quidel Corporation
Ortho Clinical Diagnostics
Sysmex Corporation
Roche Diagnostics
Becton, Dickinson and Company

These companies have a strong presence in the market, with a wide range of products and a large customer base. They are investing heavily in research and development to bring innovative products to the market and maintain their competitive edge.

Apart from the major players, several smaller companies are also operating in the IVD quality control market. These companies are focused on developing niche products and catering to specific customer segments. Some of these companies include:

Bio-Techne Corporation
Streck, Inc.
BioMérieux SA
ZeptoMetrix Corporation
Maine Standards Company, LLC

The IVD quality control market is also witnessing increasing consolidation, with major players acquiring smaller companies to expand their product portfolio and increase their market share. For example, in 2020, Bio-Rad Laboratories, Inc. acquired Celsee, Inc., a company focused on the development of microfluidic technology for single-cell analysis.

Download an Illustrative Overview:

Overall, the IVD quality control market is expected to grow significantly in the coming years, driven by increasing demand for accurate and reliable diagnostic tests. The market is likely to remain highly competitive, with major players investing heavily in research and development to bring innovative products to the market and maintain their competitive edge.